Tech Company Financing Transactions
ESBATech AG Funding Round
ESBATech AG closed a $41 million Series B financing round on 8/2/2006. Investors included SV Health Investors, Clarus and HBM Healthcare Investments.
Transaction Overview
Company Name
Announced On
8/2/2006
Transaction Type
Venture Equity
Amount
$41,000,000
Round
Series B
Investors
SV Health Investors (Lead Investor) (Graham Boulnois)
Clarus (Michael Steinmetz)
Proceeds Purpose
This financing round enables us to further develop and advance our lead product, ESBA105, in several inflammatory indications to completion of clinical Phase IIa and to progress additional antibody fragment candidates into clinical development over the next three years.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Wagistrasse 21
Zurich-Schlieren, CH
Switzerland
Zurich-Schlieren, CH
Switzerland
Phone
Website
Email Address
Overview
Privately-held ESBATech AG is a Zurich, Switzerland based drug discovery and development company focused on advancing antibody fragments for therapeutic applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
VP - R & D
Dominik Escher
Browse more venture capital transactions:
Prev: 8/2/2006: BharatMatrimony.com venture capital transaction
Next: 8/2/2006: Biodel venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs